|
Summary Information: Foghorn Therapeutics Inc. Common Stock NASDAQ:FHTX |
  admin@troach.net |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Foghorn Therapeutics is pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for therapeutic intervention. The Company's proprietary Gene Traffic Control® platform gives it an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate and potentially drug targets within the system.
__The following are links to various summary and news pages for __Foghorn Therapeutics Inc. Common Stock [ FHTX ]. __Note: Some Links might not have information for the company. |
|